Article Text

other Versions

PDF

Endobronchial Ultrasound Guided Transbronchial Needle Aspiration in the Diagnosis of Lymphoma.
  1. Marcus P Kennedy (mpkennedy{at}uams.edu)
  1. MD Anderson Cancer Center, United States
    1. Carlos A Jimenez (cajimenez{at}mdanderson.org)
    1. MD Anderson Cancer Center, United States
      1. John F Bruzzi (bruzzij2002{at}yahoo.co.uk)
      1. MD Anderson Cancer Center, United States
        1. Ashwini D Mhatre (admhatre{at}mdanderson.org)
        1. MD Anderson Cancer Center, United States
          1. Xiudong Lei (xiulei{at}mdanderson.org)
          1. MD Anderson Cancer Center, United States
            1. Francis J Giles (frankgiles{at}aol.com)
            1. MD Anderson Cancer Center, United States
              1. Tina Fanning (tfanning{at}mdanderson.org)
              1. MD Anderson Cancer Center, United States
                1. Rodolfo C Morice (rmorice{at}mdanderson.org)
                1. University of Texas MD Anderson Cancer Center, United States
                  1. George A Eapen (geapen{at}mdanderson.org)
                  1. University of Texas MD Anderson Cancer Center, United States

                    Abstract

                    Background: The diagnostic accuracy of endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA) for the diagnosis of lymphoma in patients with mediastinal lymphadenopathy is not well defined.

                    Methods: A retrospective review was performed of all patients with mediastinal lymphadenopathy referred for EBUS-TBNA between August 2005 and December 2006, in whom lymphoma was suspected based on prior history or clinical presentation. Mediastinal biopsies were taken using a linear array ultrasonic bronchoscope (Olympus XBF-UC 160F) and a 22 gauge cytology needle (NA-202C Olympus ltd.) with on-site cytopathologic support. The EBUS-TBNA result was compared to a reference standard of pathological tissue diagnosis or a composite of > 6 month's clinical follow-up with radiographic imaging.

                    Results: Of 236 patients who underwent EBUS-TBNA, 25 patients were eligible for inclusion. Indications for EBUS-TBNA were suspected mediastinal recurrence of lymphoma (n=13) and mediastinal lymphadenopathy of unknown cause (n=12). Adequate lymph node sampling was accomplished in 24/25 patients (96%); there were no complications. EBUS-TBNA identified lymphoma in 10 patients and benign disease in 14 patients. There was 1 false negative EBUS-TBNA for lymphoma (lymphoma prevalence 11/25 (44%)). Follow-up over a median of 10.5 months (range 1-19) confirmed stable or regressive lymphadenopathy in all 14 patients without a lymphoma diagnosis, consistent with a benign diagnosis. Overall, EBUS-TBNA had a sensitivity of 90.9%, specificity of 100%, positive predictive value of 100%, and negative predictive value of 92.9% for the diagnosis of lymphoma.

                    Conclusions: EBUS-TBNA is an accurate, safe and useful tool in the investigation of suspected lymphoma with isolated mediastinal adenopathy, and may diminish the need for more invasive procedures such as mediastinoscopy.

                    • Bronchoscopy
                    • Endobronchial Ultrasound
                    • Lymphoma

                    Statistics from Altmetric.com

                    Request permissions

                    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.